Health Archive

CSOFT’s health sciences blog aims to provide a better understanding of complex diseases, and regulatory polices from conducting experiments to introducing new type of drugs into the market.

Home 9 Health 9 Archive

Europe Runs Low on Pneumonia Vaccine as Demand Grows

With the spike in COVID-19 cases worldwide, there is an increasing amount of people who are seeking precautionary vaccines for respiratory issues in preparation for the winter. Merck’s Pneumovax 23, more specifically, has hit record high sale volumes worldwide in the...

At-Home COVID-19 Test Approved by FDA

Today (10/19), the U.S. Food and Drug Administration (FDA) approved Eurofins U.S Clinical Diagnostics at-home COVID-19 test which provides test result within 24 hours and is minimally invasive. This is the first FDA approved self-administered test in circulation from...

GE Healthcare Introduces Edison HealthLink

Today (10/14), GE announced its new technological innovation to healthcare data collection and safeguarding called Edison HealthLink. It will give clinicians multiple points of access to the Edison ecosystem, enabling them to make fast decisions when needed by...

Russia Approves Trial for COVID-19 Vaccine

Russia’s Health Ministry approved the usage of the “Sputnik” COVID-19 trial vaccine on 110 60+ year-olds today (10/13) in the wake of the deadly virus. Alongside this test will be a larger scale test being carried out in Moscow on 40,000 volunteers as part of a third...

NDMA Detected in Dangerous Amounts in Metroformin by FDA

Marksans Pharma and Sun Biophamrmaceuticals Industries are facilitating recalls through the FDA of their drug Metaformin as a result of high NDMA (N-nitrosodimethylamine) it contains. The FDA released a comprehensive list of Metaformin products being recalled. It is...

Chinese COVID-19 Trial Approaching End

A United Arab Emirates company, Group42 or G42, is nearing the end of phase 3 clinical trials for a Chinese COVID-19 vaccine. They are hoping to start producing in the masses next year. This potential vaccine was a product of the partnership between G42, an Abu-Dhabi...